EDITORIAL
Published on 28 Sep 2022
Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence
doi 10.3389/fmolb.2022.1034990
- 1,059 views
- 2 citations
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Breast Cancer Resistance, Biomarkers and Therapeutics Development in the Era of Artificial Intelligence
Breast Cancer Resistance, Biomarkers and Therapeutics Development in the Era of Artificial Intelligence
19k
Total Downloads
89k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 06 Jul 2022
The Multi-Functional Roles of CCR7 in Human Immunology and as a Promising Therapeutic Target for Cancer Therapeutics
doi 10.3389/fmolb.2022.834149
- 7,240 views
- 15 citations
BRIEF RESEARCH REPORT
Published on 17 May 2022
Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
doi 10.3389/fmolb.2022.818493
- 1,445 views
- 3 citations
REVIEW
Published on 14 Apr 2022
‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’
doi 10.3389/fmolb.2022.783494
- 5,841 views
- 8 citations
REVIEW
Published on 28 Mar 2022
Interrelated Oncogenic Viruses and Breast Cancer
doi 10.3389/fmolb.2022.781111
- 7,040 views
- 17 citations
ORIGINAL RESEARCH
Published on 23 Feb 2022
Immune Cell Infiltration and Relevant Gene Signatures in the Tumor Microenvironment that Significantly Associates With the Prognosis of Patients With Breast Cancer
doi 10.3389/fmolb.2022.823911
- 2,293 views
- 3 citations
REVIEW
Published on 21 Feb 2022
Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
doi 10.3389/fmolb.2022.783450
- 21,105 views
- 53 citations
ORIGINAL RESEARCH
Published on 14 Feb 2022
The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach
doi 10.3389/fmolb.2022.783735
- 2,904 views
- 4 citations
REVIEW
Published on 25 Jan 2022
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
doi 10.3389/fmolb.2022.836417
- 55,117 views
- 180 citations
ORIGINAL RESEARCH
Published on 26 Oct 2021
Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation
doi 10.3389/fmolb.2021.716735
- 3,030 views
- 20 citations
ORIGINAL RESEARCH
Published on 21 Sep 2021
Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
doi 10.3389/fmolb.2021.752154
- 1,911 views
- 2 citations
ORIGINAL RESEARCH
Published on 28 Jun 2021
Mutational Landscape of Pirin and Elucidation of the Impact of Most Detrimental Missense Variants That Accelerate the Breast Cancer Pathways: A Computational Modelling Study
doi 10.3389/fmolb.2021.692835
- 2,609 views
- 30 citations
Published in
Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
Impact
- 89kTopic views
- 68kArticle views
- 19kArticle downloads